|
1
|
Tricuspid annular displacement predicts survival in pulmonary hypertension.
|
Am J Respir Crit Care Med
|
2006
|
3.59
|
|
2
|
Association of the metabolic syndrome with pulmonary venous hypertension.
|
Chest
|
2009
|
2.75
|
|
3
|
EIF2AK4 mutations in pulmonary capillary hemangiomatosis.
|
Chest
|
2014
|
1.88
|
|
4
|
PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support.
|
Circ Heart Fail
|
2008
|
1.75
|
|
5
|
High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension.
|
Circ Heart Fail
|
2013
|
1.70
|
|
6
|
Unrecognized glucose intolerance is common in pulmonary arterial hypertension.
|
J Heart Lung Transplant
|
2011
|
1.58
|
|
7
|
Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension.
|
Am J Respir Crit Care Med
|
2008
|
1.38
|
|
8
|
Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension.
|
Am J Physiol Lung Cell Mol Physiol
|
2011
|
1.25
|
|
9
|
Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread metabolic reprogramming.
|
Pulm Circ
|
2012
|
1.19
|
|
10
|
A potential role for insulin resistance in experimental pulmonary hypertension.
|
Eur Respir J
|
2012
|
1.16
|
|
11
|
Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension.
|
Nat Genet
|
2013
|
1.11
|
|
12
|
The Diastolic Pressure Gradient Does Not-and Should Not-Predict Outcomes.
|
JACC Heart Fail
|
2015
|
1.10
|
|
13
|
Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension.
|
Am J Respir Crit Care Med
|
2012
|
1.09
|
|
14
|
Oxidative injury is a common consequence of BMPR2 mutations.
|
Pulm Circ
|
2011
|
1.06
|
|
15
|
ACE2 improves right ventricular function in a pressure overload model.
|
PLoS One
|
2011
|
1.03
|
|
16
|
Idiopathic and heritable PAH perturb common molecular pathways, correlated with increased MSX1 expression.
|
Pulm Circ
|
2011
|
1.00
|
|
17
|
BMPR2 expression is suppressed by signaling through the estrogen receptor.
|
Biol Sex Differ
|
2012
|
0.95
|
|
18
|
Development of pulmonary arterial hypertension in women: interplay of sex hormones and pulmonary vascular disease.
|
Womens Health (Lond Engl)
|
2010
|
0.92
|
|
19
|
Physical activity limitation as measured by accelerometry in pulmonary arterial hypertension.
|
Chest
|
2012
|
0.92
|
|
20
|
Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension.
|
Am J Respir Crit Care Med
|
2015
|
0.91
|
|
21
|
Shorter survival in familial versus idiopathic pulmonary arterial hypertension is associated with hemodynamic markers of impaired right ventricular function.
|
Pulm Circ
|
2013
|
0.87
|
|
22
|
Right ventricular plasticity and functional imaging.
|
Pulm Circ
|
2012
|
0.87
|
|
23
|
Prostanoids but not oral therapies improve right ventricular function in pulmonary arterial hypertension.
|
JACC Heart Fail
|
2013
|
0.87
|
|
24
|
Safety of sapropterin dihydrochloride (6r-bh4) in patients with pulmonary hypertension.
|
Exp Lung Res
|
2010
|
0.86
|
|
25
|
An evidence-based knowledgebase of pulmonary arterial hypertension to identify genes and pathways relevant to pathogenesis.
|
Mol Biosyst
|
2014
|
0.84
|
|
26
|
Hyperoxia synergizes with mutant bone morphogenic protein receptor 2 to cause metabolic stress, oxidant injury, and pulmonary hypertension.
|
Am J Respir Cell Mol Biol
|
2013
|
0.84
|
|
27
|
Phosphodiesterase-5A (PDE5A) is localized to the endothelial caveolae and modulates NOS3 activity.
|
Cardiovasc Res
|
2011
|
0.83
|
|
28
|
Effect of acute arteriolar vasodilation on capacitance and resistance in pulmonary arterial hypertension.
|
Chest
|
2015
|
0.82
|
|
29
|
Combination therapy in pulmonary arterial hypertension.
|
Clin Chest Med
|
2013
|
0.80
|
|
30
|
Hysteroscopic sterilization in women with pulmonary vascular disease.
|
Mayo Clin Proc
|
2008
|
0.80
|
|
31
|
Elevation of plasma cell-free hemoglobin in pulmonary arterial hypertension.
|
Chest
|
2014
|
0.80
|
|
32
|
Hemodynamic improvement of pulmonary arterial hypertension after bariatric surgery: potential role for metabolic regulation.
|
Diabetes Care
|
2013
|
0.80
|
|
33
|
Pulmonary hypertension in women.
|
Expert Rev Cardiovasc Ther
|
2010
|
0.79
|
|
34
|
Left atrial hypertension after repeated catheter ablations for atrial fibrillation.
|
J Am Coll Cardiol
|
2011
|
0.78
|
|
35
|
Programmatic change: lung disease research in the era of induced pluripotency.
|
Am J Physiol Lung Cell Mol Physiol
|
2011
|
0.77
|
|
36
|
Metabolic Dysfunction in Pulmonary Arterial Hypertension.
|
Curr Hypertens Rep
|
2015
|
0.76
|
|
37
|
Predictors of diastolic-to-wedge gradient in patients evaluated for pulmonary hypertension.
|
PLoS One
|
2013
|
0.75
|
|
38
|
The right ventricle in pulmonary hypertension: from dogma to data.
|
Am J Respir Crit Care Med
|
2010
|
0.75
|
|
39
|
Vasodilator-responsive idiopathic pulmonary arterial hypertension: evidence for a new disease?
|
Ann Intern Med
|
2015
|
0.75
|
|
40
|
Reproducibility of intracardiac and transpulmonary biomarkers in the evaluation of pulmonary hypertension.
|
Pulm Circ
|
2013
|
0.75
|
|
41
|
Growth by association.
|
Am J Med
|
2007
|
0.75
|
|
42
|
Diagnosing acute pancreatitis.
|
Am J Med
|
2005
|
0.75
|
|
43
|
All in the family.
|
Am J Med
|
2006
|
0.75
|
|
44
|
A pressing situation.
|
Am J Med
|
2005
|
0.75
|